Document is current
Any future updates will be listed below
-
Authors
Powles, Thomas https://orcid.org/0000-0001-7760-4724
Kockx, Mark
Rodriguez-Vida, Alejo
Duran, Ignacio
Crabb, Simon J. https://orcid.org/0000-0003-3521-9064
Van Der Heijden, Michiel S.
Szabados, Bernadett
Pous, Albert Font
Gravis, Gwenaelle
Herranz, Urbano Anido https://orcid.org/0000-0003-0376-5642
Protheroe, Andrew https://orcid.org/0000-0001-9413-0575
Ravaud, Alain
Maillet, Denis
Mendez, Maria Jose https://orcid.org/0000-0002-7460-1859
Suarez, Cristina
Linch, Mark
Prendergast, Aaron https://orcid.org/0000-0002-9668-6689
van Dam, Pieter-Jan https://orcid.org/0000-0001-9074-8271
Stanoeva, Diana
Daelemans, Sofie
Mariathasan, Sanjeev
Tea, Joy S. https://orcid.org/0000-0002-3395-149X
Mousa, Kelly
Banchereau, Romain
Castellano, Daniel
-
Funding
Funding for this research was provided by:
Roche (MO29593)
The CECM received additional core funding by the UK Experimental Cancer Medicine Network. Mr Jonathan Bull and Mr Michael Jacobson also provided financial support for aspects of the biomarker analysis
- License Information
-
More Information
Article History
First Online: 15 May 2020
Free to read: This content has been made available to all.
